Abstract：OBJECTIVE: To analyze the clinical manifestations, bone X-ray findings and genetic analysis results of three short-limb inherited short stature diseases: achondroplasia (ACH), hypochondroplasia (HCH) and pseudoachondroplasia (PSACH). METHODS: The clinical manifestations, bone X-ray findings, and genetic analysis results of 10 children with genetically confirmed short-limb inherited short stature diseases, including 4 cases of ACH 3 cases of HCH, and 3 cases of PSACH, were analyzed. RESULTS: The 10 patients had a mean body height of -3.69±1.79?SD, a mean sitting height/standing height ratio of 0.65±0.03, and a mean finger spacing/body height ratio of 0.93±0.04. Four ACH cases and 3 PSACH cases showed typical bone X-ray findings; one HCH case showed a smaller sciatic notch, and another HCH case showed no widening of interpedicular distance. G380R mutation in FGFR3 gene was detected in 3 of 4 ACH cases, and Y278C mutation in the other ACH case, N540K mutation in FGFR3 gene was detected in 3 HCH cases, and heterozygous mutations in COMP gene were detected in 3 PSACH cases. CONCLUSIONS: Children with ACH and PSACH have severer short stature and skeletal deformities than children with HCH, who have mild, atypical clinical manifestations. Bone X-ray and genetic analysis are helpful for the diagnosis and differential diagnosis of the three diseases. The mutational hotspots in two genes are involved in the three diseases, which is conducive to clinical genetic diagnosis.
LI Fang,MA Hong-Wei,SONG Ying et al. Clinical analysis and genetic diagnosis of short-limb inherited short stature diseases in children[J]. CJCP, 2013, 15(11): 932-936.
Trotter TL. Health supervision for children with achondroplasia[J]. Pediatrics, 2005, 116(3): 771-783.
[2]
McKeand J, Rotta J, Hecht JT. Natural history study of pseudoachondroplasia[J]. Am J Med Genet, 1996, 63: 406-410.
[3]
Korkmaz HA, Hazan F, Dizdarer C, Tukun A. Hypochondroplasia in a child with 1620c>G (Asn540lys) mutation in FGFR3[J]. J Clin Res Pediatr Endocrinol, 2012, 4(4): 220-222.
Song SH, Balce GC, Agashe MV, Lee H, Hong SJ, Park YE, et al. New proposed clinico-radiologic and molecular criteria in hypochondroplasia: FGFR 3 gene mutations are not the only cause of hypochondroplasia[J]. Am J Med Genet A, 2012, 158A(10): 2456-2462.
[7]
Satiroglu-Tufan NL, Tufan AC, Semerci CN, Bagci H. Accurate diagnosis of a homozygous G1138A mutation in the fibroblast growth factor receptor 3 gene responsible for achondroplasia[J]. Tohoku J Exp Med, 2006, 208(2): 103-107.
[8]
Placone J, Hristova K. Direct assessment of the effect of the Gly380Arg achondroplasia mutation on FGFR3 dimerization using quantitative imaging FRET[J]. PLoS ONE, 2012, 7(10): e46678.
[9]
Heuertz S, Le Merrer M, Zabel B, Wright M, Legeai-Mallet L, Cormier-Daire V, et al. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia[J]. Eur J Hum Genet, 2006, 14(12): 1240-1247.
[10]
Bober MB, Bellus GA, Nikkel SM, Tiller GE. Hypochondrop-lasia[M] // Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K. GeneReviewsTM[internet]. Seattle(WA): University of Washington, Seattle; 1993-2013[updated 2013 Sep 26].
[11]
Xie X, Liao L, Gao J, Luo X. A novel COMP mutation in a Chinese patient with pseudoachondroplasia[J]. Gene, 2013, 522(1): 102-106.
[12]
Mabuchi A, Haga N, Ikeda T, Manabe N, Ohashi H, Takatori Y, et al. Novel mutation in exon 18 of the cartilage oligomeric matrix protein gene causes a severe pseudoachondroplasia[J]. Am J Med Genet, 2001, 104(2): 135-139.
